+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Mycophenolate Mofetil"

Organ Transplant Immunosuppressant Drugs Market Report 2025 - Product Thumbnail Image

Organ Transplant Immunosuppressant Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Graft versus host disease (GvHD) - Pipeline Insight, 2024 - Product Thumbnail Image

Graft versus host disease (GvHD) - Pipeline Insight, 2024

  • Drug Pipelines
  • August 2024
  • 180 Pages
  • Global
From
From
From
From
LUPKYNIS Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LUPKYNIS Market Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
From
From
From
  • 12 Results (Page 1 of 1)
Loading Indicator

Mycophenolate Mofetil (MMF) is a drug used in the treatment of cardiovascular diseases. It is an immunosuppressant, meaning it reduces the body's immune response. MMF is used to prevent organ rejection in patients who have undergone a heart transplant, as well as to treat certain types of heart failure. It is also used to treat autoimmune diseases such as lupus and rheumatoid arthritis. MMF works by blocking the production of certain proteins that are involved in the body's immune response. MMF is available in both oral and intravenous forms. It is typically prescribed in combination with other drugs, such as corticosteroids and cyclosporine. The drug is generally well-tolerated, but can cause side effects such as nausea, vomiting, and diarrhea. The MMF market is highly competitive, with several major pharmaceutical companies offering the drug. These include Novartis, Pfizer, Merck, and Sanofi. Other companies, such as Mylan and Teva, also offer generic versions of the drug. Show Less Read more